Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
BACKGROUND: Metformin reduces cardiovascular risk in patients with type 2 diabetes seemingly independent of lowering blood glucose concentration. We assessed the cardiovascular effects of metformin in individuals without type 2 diabetes. METHODS: We did a single-centre, double-blind, placebo-control...
Հիմնական հեղինակներ: | Preiss, D, Lloyd, S, Ford, I, McMurray, J, Holman, R, Welsh, P, Fisher, M, Packard, C, Sattar, N |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2014
|
Նմանատիպ նյութեր
-
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): A randomised controlled trial
: Preiss, D, և այլն
Հրապարակվել է: (2014) -
Metformin therapy and circulating NT-proBNP levels: the CAMERA trial
: Preiss, D, և այլն
Հրապարակվել է: (2016) -
Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study: Metabolism
: Preiss, D, և այլն
Հրապարակվել է: (2016) -
Putative miRNA biomarkers of insulin resistance and the effect of metformin: data from the CAMERA trial
: ALRamah, T, և այլն
Հրապարակվել է: (2017) -
Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial
: Alramah, T, և այլն
Հրապարակվել է: (2019)